company-logo

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Evotec Dividend Announcement

Evotec announced a monthly dividend of $0.29 per ordinary share which will be made payable on . Ex dividend date: 2019-01-11
Evotec's trailing twelve-month (TTM) dividend yield is -%

Evotec Dividend History

Ex-Div dateDividend amountDividend typePay date
2019-01-11$0.29monthly
2018-12-12$0.18monthly
2018-11-08$0.18monthly
2018-10-10$0.18monthly
2018-09-13$0.18monthly
2018-08-10$0.18monthly
2018-07-11$0.18monthly
2018-06-08$0.18monthly
2018-05-10$0.18monthly
2018-04-11$0.18monthly
2018-03-09$0.18monthly
2018-02-09$0.18monthly
2018-01-11$0.18monthly
2017-12-08$0.18monthly
2017-11-10$0.18monthly
2017-10-11$0.18monthly
2017-09-08$0.18monthly
2017-08-09$0.18monthly
2017-07-11$0.18monthly
2017-06-08$0.20monthly
2017-05-09$0.20monthly
2017-04-11$0.20monthly
2017-03-09$0.20monthly
2017-02-09$0.20monthly
2017-01-11$0.20monthly
2016-12-08$0.20monthly
2016-11-09$0.20monthly
2016-09-08$0.20monthly
2016-08-09$0.20monthly
2016-06-09$0.24monthly
2016-05-10$0.24monthly
2016-04-07$0.24monthly
2016-03-09$0.24monthly
2016-02-09$0.24monthly
2016-01-12$0.24monthly
2015-12-09$0.24monthly
2015-11-10$0.24monthly
2015-10-08$0.24monthly
2015-09-09$0.24monthly
2015-08-11$0.24monthly
2015-07-09$0.24monthly
2015-06-09$0.24monthly

Evotec Dividend per year

Evotec Dividend growth

Evotec Dividend Yield

Evotec current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Evotec stock? Use our calculator to estimate your expected dividend yield:

Evotec Financial Ratios

P/E ratio-4.61
PEG ratio0.81
P/B ratio0.82
ROE-16.30%
Payout ratio0.00%
Current ratio2.09
Quick ratio1.99
Cash Ratio0.69

Evotec Dividend FAQ

Does Evotec stock pay dividends?
Evotec does not currently pay dividends to its shareholders.
Has Evotec ever paid a dividend?
No, Evotec has no a history of paying dividends to its shareholders. Evotec is not known for its dividend payments.
Why doesn't Evotec pay dividends?
There are several potential reasons why Evotec would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Evotec ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Evotec has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Evotec a dividend aristocrat?
Evotec is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Evotec a dividend king?
Evotec is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Evotec a dividend stock?
No, Evotec is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Evotec stocks?
To buy Evotec you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Evotec stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.